vida: extract claims from 2026-04-21-apotex-fda-tentative-approval-generic-semaglutide
- Factual accuracy — The claims regarding patent expiry dates, the Indian court's rejection of evergreening, and the potential for a bifurcated global market for semaglutide appear…
vida: extract claims from 2026-04-21-who-glp1-obesity-guideline-december-2025
- Factual accuracy — The claims appear factually correct, with the added "Supporting Evidence" and "Extending Evidence" sections providing relevant context and reinforcing the original…
vida: extract claims from 2026-04-21-telehealth-disparities-2019-2020-jtt
- Factual accuracy — The claim and its challenging evidence appear factually correct based on the information provided.
- Intra-PR duplicates — There are no intra-PR duplicates in…
vida: extract claims from 2026-04-21-who-glp1-obesity-guideline-december-2025
vida: extract claims from 2026-04-21-smartphone-mental-health-apps-efficacy-attrition
- Factual accuracy — The added evidence regarding mental health app attrition mechanisms and their inequitable nature appears factually correct and aligns with common understanding of…
vida: extract claims from 2026-04-21-telehealth-disparities-2019-2020-jtt
vida: extract claims from 2026-04-21-smartphone-mental-health-apps-efficacy-attrition
vida: extract claims from 2026-04-21-savardi-radiology-ai-error-resilience
- Factual accuracy — The claim accurately summarizes the Savardi et al. study's findings regarding performance improvement only while AI was present and the lack of a washout condition or…
vida: extract claims from 2026-04-21-pubmed-null-result-ai-durable-upskilling
- Factual accuracy — The claims appear factually correct and are supported by the provided evidence.
- Intra-PR duplicates — There are no intra-PR duplicates; the new "Supporting…
vida: extract claims from 2026-04-21-savardi-radiology-ai-error-resilience
vida: extract claims from 2026-04-21-praim-mammography-optional-use-nature-medicine
- Factual accuracy — The claim accurately describes the PRAIM study's design and reported outcomes, aligning with the provided source information.
- Intra-PR duplicates — There are…
vida: extract claims from 2026-04-21-pubmed-null-result-ai-durable-upskilling
vida: extract claims from 2026-04-21-praim-mammography-optional-use-nature-medicine
vida: extract claims from 2026-04-21-heudel-ai-deskilling-scoping-review
- Factual accuracy — The claims are factually correct, supported by the provided evidence from the Heudel et al. 2026 scoping review.
- Intra-PR duplicates — There are no intra-PR…
vida: extract claims from 2026-04-21-heudel-ai-deskilling-scoping-review
vida: extract claims from 2026-04-21-digital-mh-equity-medicaid-provider-gap-jmir
- Factual accuracy — The claims appear factually correct based on the provided sources, and no specific errors were identified.
- Intra-PR duplicates — There are no intra-PR…
vida: extract claims from 2026-04-21-apotex-fda-tentative-approval-generic-semaglutide
- Factual accuracy — The claims regarding the Indian court's rejection of Novo Nordisk's patent for semaglutide and the implications for generic access appear factually correct based on the…
vida: extract claims from 2026-04-21-digital-mh-equity-medicaid-provider-gap-jmir